Clinical Outcomes of Double C-Loop Haptic Intraocular Lenses Across Different Optic Designs: A Retrospective Study Authors: Camille Bosc, Eloïse Le Malefan, Pauline Boury, Mélanie Bernier Published: 2026 ABSTRACT PurposeTo assess the visual, refractive, and rotational stability outcomes of double C-loop haptic intraocular lenses (IOLs) across different optic designs.MethodsThis retrospective study included 69 eyes implanted with PODEYE toric, Serenity toric, and FineVision HP toric IOLs (Beaver-Visitec International, Inc. USA). A total of 23 eyes per group were analyzed at 3-months postoperatively. Subjective refraction, monocular uncorrected distance visual acuity and corrected distance visual acuity (CDVA), and rotational stability were evaluated in all cases.ResultsIn the PODEYE toric IOL group, 100% of eyes were within ±0.50D with a mean spherical equivalent (SE) of 0.06±0.26D; in the Serenity toric IOL group, this percentage was 78.26% with a mean SE of –0.28±0.38D, while in the FineVision HP toric IOL group, 86.96% of eyes were within ±0.50D, with a mean SE of 0.22±0.30D (p<0.001). Mean CDVA was –0.02±0.04, –0.02±0.04, and –0.05±0.07 logMAR in the PODEYE toric, Serenity toric, and FineVision HP toric IOLs groups, respectively (p=0.047). In the PODEYE toric IOL group, 23.81% and 100% of eyes achieved a cumulative CDVA of ≥20/16 and ≥20/20, respectively. Corresponding values were 17.39% and 100% for the Serenity toric IOL group, and 52.17% and 95.65% for the FineVision HP toric IOL group. Mean IOL rotation was 1.09±0.79, 1.70±1.72 and 1.78±1.31 degrees for the PODEYE toric, Serenity toric, and FineVision HP toric IOLs groups (p=0.16). 100% of eyes exhibited rotation ≤10 degrees, and 100%, 91.30% and 100% of eyes in the PODEYE toric, Serenity toric, and FineVision HP toric IOLs groups, respectively, showed rotation ≤5 degrees (p=0.108).ConclusionDouble C-loop haptic IOLs provide excellent refractive, distance visual acuity, and rotational stability outcomes across different optic designs. Introduction Correcting pre-existing astigmatism with toric intraocular lenses (IOLs) in patients with cataract has enabled surgeons to improve refractive accuracy and visual acuity outcomes following surgery. Achieving emmetropia after both cataract and refractive lens exchange procedures is considered a hallmark of excellence in modern surgical practice. A recent report by the American Academy of Ophthalmology, which analyzed 63 publications evaluating visual and refractive outcomes as well as rotational stability in eyes implanted with toric IOLs, concluded that these lenses are effective in neutralizing corneal astigmatism, resulting in better uncorrected distance visual acuity (UDVA) and a significant reduction in refractive astigmatism after cataract surgery compared with non-toric IOLs.1 Postoperative alignment of toric IOL is critical for successful astigmatism correction since rotational instability post-surgery may significantly compromise refractive outcomes and reduce visual acuity. Several factors, including preoperative refraction, biological parameters, surgical technique, postoperative care, and long-term management, have been reported to influence IOL rotational stability.2 A systematic review and meta-analysis including 51 studies and 4863 eyes evaluated the rotational stability of toric IOLs across different IOL models and haptic designs.3 The authors concluded that postoperative IOL rotation depends on multiple aspects of IOL material and design. Notably, double-loop haptic designs demonstrated exceptional rotational stability, which may be attributed to the increased number of contact points between the haptics and the capsular bag, thereby increasing the total friction. A recent review on double C-loop haptic lenses (POD platform [BVI Inc., Waltham, USA]) concluded that this platform provides good rotational stability across different IOL models, including monofocal and trifocal optic designs, and with both hydrophilic and hydrophobic materials.4 Astigmatism correction using toric designs can be implemented across a wide range of IOL models, from monofocal to presbyopia-correcting lenses. The POD platform, characterized by a symmetrical quadripod design with 2-by-2 oppositely oriented haptics, is currently used in several toric IOLs made of hydrophobic material and has demonstrated favourable clinical outcomes in monofocal (PODEYE),5–9 trifocal (FineVision HP),10 and more recently isofocal (Serenity)11,12 optic designs. However, to the best of our knowledge, no clinical studies have directly compared the outcomes of these three IOL types within toric platforms. Therefore, the main aim of this retrospective clinical study was to assess visual acuity, refractive, and rotational stability outcomes following implantation of PODEYE toric, Serenity toric, and FineVision HP toric IOLs after cataract surgery. Materials and Methods Design and Surgical Procedure This retrospective clinical study included 69 eyes from 44 patients who underwent cataract surgery at the Institut Ophtalmologique de l’Ouest (IOO) Jules Verne (Nantes, France), with implantation of PODEYE toric, Serenity toric, or FineVision HP toric IOLs. All eyes received toric IOL models. The study was approved by the IOO Review Board (IOO-2025-2) and conducted in accordance with Good Clinical Practices and the principles of the Declaration of Helsinki with patients signing the informed consent form. Inclusion criteria comprised patients undergoing cataract phacoemulsification surgery with implantation of PODEYE toric, Serenity toric, or FineVision HP toric IOLs, and availability for a 3-month follow-up visit. Exclusion criteria included the presence of ocular diseases that could compromise postoperative visual outcomes evaluating the clinical records. All surgeries were performed by the same experienced surgeon (CB) using the EVA NEXUS system (DORC Dutch Ophthalmic Research Centre (International) B.V., Zuidland, The Netherlands) and a pop- and pre-chop technique. In all cases, the IOL was implanted in the capsular bag. Intraocular Lenses All IOLs are manufactured from the same glistening-free hydrophobic acrylic material (GFY, n=1.53 and Abbe number=42), and incorporate blue light and ultraviolet filters. They share an identical haptic design based on the POD platform, characterized by a double C-loop configuration with Ridgetech and posterior angulation. This platform provides 4 contact points with the capsular bag and allows intraoperative rotation of the lens in both clockwise or counterclockwise directions. The PODEYE toric IOL (PODT49P model) features a biconvex aspheric toric monofocal design, with spherical powers ranging from +6.00D to +30.00D in 0.50D increments. The Serenity toric IOL (PODST49P model) has an aspherical toric isofocal optic design, with spherical powers ranging from +10.00D to +30.00D in 0.50D increments and from +31.00D to +35.00D in 1.00D increments. The FineVision HP toric IOL (PODFT49P model) incorporates a biconvex aspheric toric diffractive design providing 2 additions (+3.50D and +1.75D), with spherical powers ranging from +10D.00 to +35.00D in 0.50D increments. The three IOL models share the same overall diameter (11.40 mm) and optic diameter (6.00 mm) and are available in identical cylindrical powers (1.00, 1.50, 2.25, 3.00, 3.75, 4.50, 5.25 and 6.00D, at the IOL plane). Pre- and Post-Operative Measurements Before the surgery, all patients underwent a full preoperative assessment, including optical non-contact biometry using the IOLMaster (Carl Zeiss Meditec, Jena, Germany) or the Tomey OA-2000 (Nagoya, Japan) biometers, monocular logMAR corrected distance visual acuity (CDVA) and subjective refraction (sphere, cylinder, and axis). The target refraction was emmetropia in all eyes. Intraocular lens power was calculated using the Barrett toric and BVI and ESCRS’s calculators. Postoperative assessment at 3-months included manifest refraction, monocular logMAR UDVA and CDVA, and IOL rotation. Absolute rotational stability was calculated between baseline and the 3-month postoperative visit. To determine the stability of the toric IOLs after implantation, IOL orientation at baseline was defined as the surgical position recorded intraoperatively using the Callisto system (Carl Zeiss Meditec, Jena, Germany) at the end of the surgery and, at the postoperative follow-up visit, using the slit-lamp. Statistical Analysis and Sample Size All the variables (gender, age, UDVA, CDVA, sphere, cylinder and axis, biometric parameters, rotation, and IOL powers) were entered into a database and analyzed using Microsoft Excel (2019, v. 16.43, Microsoft Corporation, USA). Descriptive statistics included mean, standard deviation, range, and 95% confidence intervals. Comparisons between groups were performed using one-way analysis of variance (ANOVA), followed by post-hoc Tukey’s tests for multiple comparisons, and Fisher’s exact test. A p value of less than 0.05 was considered statistically significant. The sample size was calculated assuming a two‑sided alpha of level of 0.05, 80% statistical power, equal group sizes, and based on previously reported rotation outcomes for the PODEYE toric IOL (2.52±2.59 degrees).7 Under these assumptions, a minimum of 23 eyes per group was required. Refraction accuracy (spherical equivalent and cylinder) and visual acuity outcomes were graphically represented using standard plots.13 In addition, astigmatism analysis was performed using a double-angle plot method,14 incorporating preoperative corneal astigmatism and the postoperative refractive astigmatism data. Results A total of 69 eyes from 44 patients (23 male) implanted with PODEYE toric, Serenity toric, or FineVision HP toric IOLs were included in this study (23 eyes per group). The same IOL model was implanted in each patient. Demographic and preoperative characteristics of the three groups are summarized in Table 1 and are presented as mean, standard deviation, range, and 95% confidence intervals. Statistically significant differences were observed among the three groups in age, sphere, cylinder, spherical equivalent, CDVA, K2, anterior chamber depth, white-to-white, and both spherical and cylindrical IOL power (p<0.05). In contrast, no significant differences were found for axial length, K1, or lens thickness.Table 1Demographics and Preoperative Characteristics of the Different Intraocular Lens Groups Included in This Study, Shown as Means, Standard Deviations, Ranges, and 95% Confidence IntervalsPODEYE ToricSerenity ToricFineVision HP ToricP valueEyes (n)232323—Patients (n)141515—Sex (male/female)6/88/79/6—Age (y)72.65±4.00(65 to 80)[70.92, 74.38]72.61±8.80(57 to 94)[68.80, 76.42]60.96±7.40(42 to 76)[57.76, 64.16]<0.001*Sphere (D)–1.34±3.18(–10.50 to 4.75)[–2.71, 0.04]0.97±2.24(–6.50 to 4.50)[0.00, 1.94]0.95±2.24(–4.50 to 4.00)[–0.02, 1.91]0.004*Cylinder (D)–1.99±1.59(–5.50 to 0.00)[–2.68, –1.30]–1.32±0.58(–3.25 to 0.50)[–1.57, –1.06]–0.89±0.48(–2.00 to –0.25)[–1.10, –0.69]0.002*Spherical Equivalent (D)–2.33±3.48(–13.25 to 4.25)[–3.84, –0.83]0.31±2.37(–8.13 to 3.75)[–0.71, 1.33]0.50±2.41(–5.50 to 3.63)[–0.50, 1.54]0.001*CDVA (logMAR)0.20±0.10(0.10 to 0.50)[0.16, 0.25]0.12±0.08(0.00 to 0.30)[0.08, 0.15]0.10±0.14(–0.10 to 0.40)[0.03, 0.16]0.004*Axial length (mm)24.25±1.37(22.37 to 27.26)[23.66, 24.85]23.59±0.87(21.76 to 25.61)[23.21, 23.97]23.89±1.22(22.35 to 25.88)[23.37, 24.42]0.170K1 (D)42.94±1.14(40.70 to 45.12)[42.45, 43.44]42.93±1.50(39.91 to 46.13)[42.28, 43.58]42.88±1.10(40.96 to 45.17)[42.41, 43.36]0.990K2 (D)44.99±1.22(43.11 to 46.98)[44.46, 45.51]44.15±1.57(41.92 to 47.53)[43.47, 44.83]43.94±1.20(41.75 to 46.80)[43.42, 44.46]0.025*ACD (mm)3.08±0.29(2.49 to 3.46)[2.95, 3.20]3.02±0.31(2.35 to 3.42)[2.89, 3.16]3.29±0.30(2.64 to 3.79)[3.16, 3.42]0.010*LT (mm)4.73±0.43(4.14 to 5.79)[4.54, 4.91]4.68±0.33(4.03 to 5.14)[4.53, 4.83]4.53±0.33(3.80 to 5.12)[4.38, 4.67]0.170WTW (mm)11.98±0.25(11.50 to 12.40)[11.87, 12.09]11.85±0.37(11.10 to 12.58)[11.68, 12.02]12.18±0.39(11.30 to 12.90)[12.01, 12.35]0.008*IOL spherical power (D)18.89±4.32(8.00 to 26.00)[17.02, 20.76]21.72±2.00(17.50 to 26.00)[20.85, 22.58]20.76±3.39(14.50 to 26.50)[19.29, 22.23]0.020*IOL cylindrical power (D)2.54±1.36(1.00 to 6.00)[1.95, 3.13]1.39±0.46(1.00 to 2.25)[1.19, 1.59]1.25±0.44(1.00 to 2.25)[1.06, 1.44]<0.001*Note: * statistically significant differences.Abbreviations: IOL, intraocular lens; D, dioptres. Table 1Demographics and Preoperative Characteristics of the Different Intraocular Lens Groups Included in This Study, Shown as Means, Standard Deviations, Ranges, and 95% Confidence IntervalsPODEYE ToricSerenity ToricFineVision HP ToricP valueEyes (n)232323—Patients (n)141515—Sex (male/female)6/88/79/6—Age (y)72.65±4.00(65 to 80)[70.92, 74.38]72.61±8.80(57 to 94)[68.80, 76.42]60.96±7.40(42 to 76)[57.76, 64.16]<0.001*Sphere (D)–1.34±3.18(–10.50 to 4.75)[–2.71, 0.04]0.97±2.24(–6.50 to 4.50)[0.00, 1.94]0.95±2.24(–4.50 to 4.00)[–0.02, 1.91]0.004*Cylinder (D)–1.99±1.59(–5.50 to 0.00)[–2.68, –1.30]–1.32±0.58(–3.25 to 0.50)[–1.57, –1.06]–0.89±0.48(–2.00 to –0.25)[–1.10, –0.69]0.002*Spherical Equivalent (D)–2.33±3.48(–13.25 to 4.25)[–3.84, –0.83]0.31±2.37(–8.13 to 3.75)[–0.71, 1.33]0.50±2.41(–5.50 to 3.63)[–0.50, 1.54]0.001*CDVA (logMAR)0.20±0.10(0.10 to 0.50)[0.16, 0.25]0.12±0.08(0.00 to 0.30)[0.08, 0.15]0.10±0.14(–0.10 to 0.40)[0.03, 0.16]0.004*Axial length (mm)24.25±1.37(22.37 to 27.26)[23.66, 24.85]23.59±0.87(21.76 to 25.61)[23.21, 23.97]23.89±1.22(22.35 to 25.88)[23.37, 24.42]0.170K1 (D)42.94±1.14(40.70 to 45.12)[42.45, 43.44]42.93±1.50(39.91 to 46.13)[42.28, 43.58]42.88±1.10(40.96 to 45.17)[42.41, 43.36]0.990K2 (D)44.99±1.22(43.11 to 46.98)[44.46, 45.51]44.15±1.57(41.92 to 47.53)[43.47, 44.83]43.94±1.20(41.75 to 46.80)[43.42, 44.46]0.025*ACD (mm)3.08±0.29(2.49 to 3.46)[2.95, 3.20]3.02±0.31(2.35 to 3.42)[2.89, 3.16]3.29±0.30(2.64 to 3.79)[3.16, 3.42]0.010*LT (mm)4.73±0.43(4.14 to 5.79)[4.54, 4.91]4.68±0.33(4.03 to 5.14)[4.53, 4.83]4.53±0.33(3.80 to 5.12)[4.38, 4.67]0.170WTW (mm)11.98±0.25(11.50 to 12.40)[11.87, 12.09]11.85±0.37(11.10 to 12.58)[11.68, 12.02]12.18±0.39(11.30 to 12.90)[12.01, 12.35]0.008*IOL spherical power (D)18.89±4.32(8.00 to 26.00)[17.02, 20.76]21.72±2.00(17.50 to 26.00)[20.85, 22.58]20.76±3.39(14.50 to 26.50)[19.29, 22.23]0.020*IOL cylindrical power (D)2.54±1.36(1.00 to 6.00)[1.95, 3.13]1.39±0.46(1.00 to 2.25)[1.19, 1.59]1.25±0.44(1.00 to 2.25)[1.06, 1.44]<0.001*Note: * statistically significant differences.Abbreviations: IOL, intraocular lens; D, dioptres. Demographics and Preoperative Characteristics of the Different Intraocular Lens Groups Included in This Study, Shown as Means, Standard Deviations, Ranges, and 95% Confidence Intervals Note: * statistically significant differences. Abbreviations: IOL, intraocular lens; D, dioptres. Refractive Error Outcomes Table 2 summarizes the postoperative outcomes across the three groups for the different parameters. Figure 1 illustrates refractive accuracy at 3 months, with spherical equivalent shown in Figure 1A and refractive cylinder in Figure 1B. In the PODEYE toric IOL group, 100% of eyes were within ±0.50D. The mean spherical equivalent (SE) was 0.06±0.26D (range: −0.50D to 0.50D), and the mean cylinder was −0.29±0.33D (range: 0D to −1.00D). In the Serenity toric IOL group, 78.26% of eyes were within ±0.50D and 95.65% were within ±1.00D. The mean SE was −0.28±0.38D (range: −1.25D to 0.50D), and the mean cylinder was −0.40±0.26D (range: 0D to −0.75D). In the FineVision HP toric IOL group, 86.96% of eyes were within ±0.50D and 100% were within ±1.00D. The mean SE was 0.22±0.30D (range: −0.13D to 1.00D), and the mean cylinder was −0.14±0.20D (range: 0D to −0.50D). Statistical analysis revealed a significant difference in SE between groups (p<0.001). Post hoc comparisons demonstrated that the Serenity toric IOL group differed significantly from the both FineVision HP toric IOL (p<0.001) and the PODEYE toric IOL (p = 0.002) groups, whereas no significant difference was observed between the FineVision HP toric IOL and the PODEYE toric IOL groups (p=0.195). For refractive cylinder, a statistically significant difference was also observed between groups (p=0.006). Post hoc analysis showed a significant difference between the FineVision HP toric IOL and the Serenity toric IOL groups (p=0.004), while no significant differences were found between FineVision HP toric and PODEYE toric IOLs or between PODEYE toric and Serenity toric IOLs.Table 2Refractive, Visual Acuity and Rotational Stability Outcomes of the Different Intraocular Lens Groups Included in This Study, Shown as Means, Standard Deviations, Ranges, and 95% Confidence IntervalsPODEYE ToricSerenity ToricFineVision HP ToricP-valueSpherical Equivalent (D)0.06±0.26(–0.50 to 0.50)[–0.05, 0.17]–0.28±0.38(–1.25 to 0.50)[–0.44, –0.11]0.22±0.30(–0.13 to 1.00)[0.09, 0.35]<0.001*Refractive Cylinder (D)–0.29±0.33(–1.00 to 0.00)[–0.43, –0.15]–0.40±0.26(–0.75 to 0.00)[–0.51, 0.30]–0.14±0.20(–0.50 to 0.00)[–0.23, –0.06]0.006*UDVA (logMAR)–0.01±0.09(–0.20 to 0.10)[–0.05, 0.02]0.07±0.11(–0.10 to 0.30)[0.02, 0.12]–0.03±0.06(–0.10 to 0.10)[–0.06, –0.01]<0.001*CDVA (logMAR)–0.02±0.04(–0.10 to 0.00)[–0.04, 0.00]–0.02±0.04(–0.10 to 0.00)[–0.03, 0.00]–0.05±0.07(–0.20 to 0.10)[–0.08, –0.02]0.047*Rotation (degrees)1.09±0.79(0 to 2)[0.75, 2.44]1.70±1.72(0 to 6)[0.95, 2.44]1.78±1.31(0 to 5)[1.21, 2.35]0.16Eyes with a rotation ≤ 5 degrees (%)10091.301000.108Eyes with a rotation ≤ 10 degrees (%)100100100—Note: * statistically significant differences. Figure 1Distribution of postoperative spherical equivalent refraction (A) and refractive cylinder (B) after surgery for the PODEYE toric, Serenity toric, and FineVision HP toric intraocular lens groups.The image A showing a grouped bar graph titled Postoperative Spherical Equivalent Refraction left parenthesis D right parenthesis. Y axis label percent of eyes, range 0 to 60. X axis label Postoperative Spherical Equivalent Refraction left parenthesis D right parenthesis with bins: less than minus 2.00; minus 2.00 to minus 1.51; minus 1.50 to minus 1.01; minus 1.00 to minus 0.51; minus 0.50 to 0.14; minus 0.13 to plus 0.13; plus 0.14 to plus 0.50; plus 0.51 to plus 1.00; plus 1.01 to plus 1.50; plus 1.51 to plus 2.00; greater than plus 2.00. Legend: PODEYE TORIC, SERENITY TORIC, FINEVISION HP TORIC. Visible bar values: SERENITY TORIC 4.35 at minus 1.50 to minus 1.01; SERENITY TORIC 17.39 at minus 1.00 to minus 0.51; PODEYE TORIC 17.39 and SERENITY TORIC 39.13 at minus 0.50 to 0.14; PODEYE TORIC 39.13 and SERENITY TORIC 30.43 and FINEVISION HP TORIC 52.17 at minus 0.13 to plus 0.13; PODEYE TORIC 43.48 and SERENITY TORIC 8.70 and FINEVISION HP TORIC 34.78 at plus 0.14 to plus 0.50; FINEVISION HP TORIC 13.04 at plus 0.51 to plus 1.00. Text annotations: PODEYE TORIC 100 percent plus or minus 0.50 D; 100 percent plus or minus 1.00 D. SERENITY TORIC 78.26 percent plus or minus 0.50 D; 95.65 percent plus or minus 1.00 D. FINEVISION HP TORIC 86.96 percent plus or minus 0.50 D; 100 percent plus or minus 1.00 D. The image B showing a grouped bar graph titled Postoperative Refractive Cylinder left parenthesis D right parenthesis. Y axis label percent of eyes, range 0 to 90. X axis label Postoperative Refractive Cylinder left parenthesis D right parenthesis with categories: less than or equal to 0.25; 0.50; 0.75; 1.00. Legend: PODEYE TORIC, SERENITY TORIC, FINEVISION HP TORIC. Visible bar values: at less than or equal to 0.25, PODEYE TORIC 56.52, SERENITY TORIC 43.48, FINEVISION HP TORIC 82.61; at 0.50, PODEYE TORIC 26.09, SERENITY TORIC 34.78, FINEVISION HP TORIC 17.39; at 0.75, PODEYE TORIC 13.04, SERENITY TORIC 21.74; at 1.00, PODEYE TORIC 4.35. Text annotations: PODEYE TORIC 82.61 percent less than or equal to 0.50 D; 100 percent less than or equal to 1.00 D. SERENITY TORIC 78.26 percent less than or equal to 0.50 D; 100 percent less than or equal to 1.00 D. FINEVISION HP TORIC 100 percent less than or equal to 0.50 D; 100 percent less than or equal to 1.00 D.Post-op refraction and cylinder by lens group shown in bar graphs. Table 2Refractive, Visual Acuity and Rotational Stability Outcomes of the Different Intraocular Lens Groups Included in This Study, Shown as Means, Standard Deviations, Ranges, and 95% Confidence IntervalsPODEYE ToricSerenity ToricFineVision HP ToricP-valueSpherical Equivalent (D)0.06±0.26(–0.50 to 0.50)[–0.05, 0.17]–0.28±0.38(–1.25 to 0.50)[–0.44, –0.11]0.22±0.30(–0.13 to 1.00)[0.09, 0.35]<0.001*Refractive Cylinder (D)–0.29±0.33(–1.00 to 0.00)[–0.43, –0.15]–0.40±0.26(–0.75 to 0.00)[–0.51, 0.30]–0.14±0.20(–0.50 to 0.00)[–0.23, –0.06]0.006*UDVA (logMAR)–0.01±0.09(–0.20 to 0.10)[–0.05, 0.02]0.07±0.11(–0.10 to 0.30)[0.02, 0.12]–0.03±0.06(–0.10 to 0.10)[–0.06, –0.01]<0.001*CDVA (logMAR)–0.02±0.04(–0.10 to 0.00)[–0.04, 0.00]–0.02±0.04(–0.10 to 0.00)[–0.03, 0.00]–0.05±0.07(–0.20 to 0.10)[–0.08, –0.02]0.047*Rotation (degrees)1.09±0.79(0 to 2)[0.75, 2.44]1.70±1.72(0 to 6)[0.95, 2.44]1.78±1.31(0 to 5)[1.21, 2.35]0.16Eyes with a rotation ≤ 5 degrees (%)10091.301000.108Eyes with a rotation ≤ 10 degrees (%)100100100—Note: * statistically significant differences. Refractive, Visual Acuity and Rotational Stability Outcomes of the Different Intraocular Lens Groups Included in This Study, Shown as Means, Standard Deviations, Ranges, and 95% Confidence Intervals Note: * statistically significant differences. Distribution of postoperative spherical equivalent refraction (A) and refractive cylinder (B) after surgery for the PODEYE toric, Serenity toric, and FineVision HP toric intraocular lens groups. Figure 1B shows the distribution of refractive cylinder across the three groups. In the PODEYE toric, Serenity toric and FineVision HP toric IOLs groups, 82.61%, 78.26% and 100% of the eyes were ≤0.50D, respectively, while 100% of eyes in all groups were ≤1.00D. Figure 2 depicts the double-angle plots of preoperative corneal astigmatism and postoperative refractive astigmatism. The postoperative refractive astigmatism centroid was 0.05±0.44D at 1 degree, 0.14±0.46D at 156 degrees and 0.04±0.24D at 111 degrees for the PODEYE toric, Serenity toric and FineVision HP toric IOLs groups, respectively. The mean absolute astigmatism was reduced from 2.04±0.96D preoperatively to 0.29±0.32D at 3 months after the intervention in the PODEYE toric IOL group, from 1.22±0.44D to 0.40±0.25D in the Serenity toric IOL group, and from 1.06±0.54D to 0.14±0.19D in the FineVision HP toric IOL group. Figure 2Double-angle plots for preoperative corneal astigmatism and postoperative refractive astigmatism after surgery for the PODEYE toric (A), Serenity toric (B) and FineVision HP toric (C) intraocular lens groups. Centroids and mean absolute values with standard deviations are also shown.A) Two polar scatter plots with angular ticks from 0 to 180 degrees. Radial scale: each ring equals 1.00 D. Left plot: yellow points spread to 3 rings; wide blue ellipse; red centroid ellipse near 90 degrees. Text: Centroid 1.24 D at 88 degrees ± 1.92 D; Mean Absolute 2.04 D ± 0.96 D. Right plot: points within 1 ring; smaller blue ellipse; red ellipse near center. Text: Centroid 0.05 D at 1 degree ± 0.44 D; Mean Absolute 0.29 D ± 0.32 D; N=23. B) Same axes and scale. Left text: Centroid 0.19 D at 52 degrees ± 1.31 D; Mean Absolute 1.22 D ± 0.44 D. Right text: Centroid 0.14 D at 156 degrees ± 0.46 D; Mean Absolute 0.40 D ± 0.25 D; N=23. C) Same axes and scale. Left text: Centroid 0.57 D at 90 degrees ± 1.07 D; Mean Absolute 1.06 D ± 0.54 D. Right text: Centroid 0.04 D at 111 degrees ± 0.24 D; Mean Absolute 0.14 D ± 0.19 D; N=23. Legend: black square centroid; red ellipse 95% confidence of centroid; blue ellipse 95% confidence of dataset.Double-angle polar scatter plots of corneal and refractive astigmatism, showing tighter postoperative clustering. Double-angle plots for preoperative corneal astigmatism and postoperative refractive astigmatism after surgery for the PODEYE toric (A), Serenity toric (B) and FineVision HP toric (C) intraocular lens groups. Centroids and mean absolute values with standard deviations are also shown. Visual Acuity Outcomes Table 2 also summarizes the mean, standard deviation, range, and 95% confidence intervals for UDVA and CDVA across the three groups. Statistically significant differences were observed among the groups for both parameters (p<0.05). For UDVA, the Serenity toric IOL group showed significantly lower values compared to both the FineVision HP toric IOL (p<0.001) and PODEYE toric IOL (p=0.007) groups, whereas no significant difference was observed between the latter two groups (p=0.722). In contrast, for CDVA, although a significant overall difference was observed among the groups, post hoc comparisons did not reveal statistically significant differences between any pair of groups (all p>0.05). Figure 3 plots the cumulative percentage of eyes achieving a given UDVA and CDVA across the three groups. In the PODEYE toric IOL group, 23.81% and 100% of eyes achieved a cumulative CDVA of ≥20/16 and ≥20/20, respectively. Corresponding values were 17.39% and 100% for the Serenity toric IOL group, and 52.17% and 95.65% for the FineVision HP toric IOL group. Figure 3Cumulative proportion of eyes after surgery for the PODEYE toric (A), Serenity toric (B) and FineVision HP toric (C) intraocular lens groups with a given uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA).The images A, B and C depict grouped bar graphs titled ′Cumulative U D V A and C D V A (20/x or better)′. Each graph shares the same X-axis categories: 20/16, 20/20, 20/25, 20/32, 20/40 and a Y-axis labeled ′Cumulative percent of Eyes′, ranging from 0 to 100. The legend includes U D V A and C D V A. In Image A: - At 20/16, both U D V A and C D V A are 23.81. - At 20/20, U D V A is 80.95, C D V A is 100. - At 20/25, 20/32 and 20/40, both are 100. In Image B: - At 20/16, U D V A is 9.52, C D V A is 17.39. - At 20/20, U D V A is 47.62, C D V A is 100. - At 20/25, U D V A is 80.95, C D V A is 100. - At 20/32, U D V A is 90.48, C D V A is 100. - At 20/40, both are 100. In Image C: - At 20/16, U D V A is 43.48, C D V A is 52.17. - At 20/20, U D V A is 91.30, C D V A is 95.65. - At 20/25, 20/32 and 20/40, both are 100.Bar graphs showing cumulative percent of eyes by uncorrected and corrected distance visual acuity thresholds. Cumulative proportion of eyes after surgery for the PODEYE toric (A), Serenity toric (B) and FineVision HP toric (C) intraocular lens groups with a given uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA). Rotation Outcomes Table 2 also reports the mean, standard deviation, range, and 95% confidence interval values for IOL rotation across the three groups. Statistical analysis did not reveal a significant difference in rotation between groups (p=0.16). Overall, 100% of eyes exhibited a rotation ≤10 degrees. Regarding the ≤5 degrees threshold, 100%, 91.30%, and 100% of eyes in the PODEYE toric, Serenity toric, and FineVision HP toric IOLs groups, respectively, were within this limit. Comparison of the proportions of eyes with rotation ≤5 degrees showed no statistically significant differences between groups (p=0.108). Discussion Different clinical studies have reported that the PODEYE toric,5–9 FineVision HP toric,15,16 and Serenity (non-toric)11,12 IOLs provide good refractive outcomes and excellent visual acuity when implanted. The purpose of our study is to compare the outcomes of the three types of toric IOLs based on the POD platform with double C-loop haptics, in order to confirm the stability of the platform across different optical designs. PODEYE Toric IOL Several publications have analyzed the outcomes of the PODEYE toric IOL.5–8 Ang et al7 in particular, reported the outcomes for a large cohort of 236 eyes at 12-months post-surgery in a prospective multicenter study conducted across several countries. These authors found that 74.6% and 95.8% of eyes were within ±0.50D and ±1.00D of the target refraction, respectively. Additionally, 78.0% and 97.5% of eyes showed a postoperative refractive cylinder of ≤0.50D and ≤1.00D, respectively. The mean manifest SE and refractive cylinder values were 0.16±0.40D and −0.42±0.33D, respectively. Our results are consistent with those reported in this study, confirming the accuracy of the procedure when the PODEYE toric IOL is implanted. Figure 1A shows that 100% of eyes were within ±0.50D, with a mean SE close to emmetropia (0.06±0.26D). Figure 1B shows that 82.61% and 100% of eyes were ≤0.50D and ≤1.00D, respectively, with a mean refractive cylinder about a quarter of diopter (−0.29±0.33D). Accurate refractive outcomes are expected to be associated with good visual acuity outcomes, as uncorrected astigmatism reduces visual acuity. In our study, 23.81% and 100% of eyes achieved a cumulative CDVA of ≥20/16 and ≥20/20, respectively, while 23.81% and 80.95% of eyes achieve these values for cumulative UDVA (Figure 3A). Mean UDVA and CDVA were better than 20/20 (–0.01±0.09 and –0.02±0.04 logMAR, respectively, see Table 2). Ang et al7 also reported that 89.4% and 94.9% of eyes achieved monocular UDVA and CDVA of ≤0.2 logMAR, respectively. The mean monocular UDVA and CDVA were 0.08±0.11 and 0.01±0.09 logMAR, respectively. It should be noted that the rotational stability of the toric IOL is a key determinant of postoperative effectiveness. Any postoperative IOL rotation may reduce astigmatic correction and, in cases of significant rotation, may even induce astigmatism. A reduction of approximately 15% in cylindrical correction occurs for every 5 degrees of misalignment of a toric IOL.17 Therefore, stable haptics are essential to ensure optimal rotational stability. In the study by Ang et al7 the mean absolute IOL rotation was 2.52±2.59 degrees, with 98.56% of eyes showing a rotation <10 degrees. The multicenter study7 concluded that this toric IOL model provides good visual and refractive outcomes in cataract patients with astigmatism, with a mean absolute rotation of <2.6 degrees. Our findings support this conclusion, with a mean rotation of 1.09±0.79 degrees and 100% of eyes showing a rotation ≤5 degrees. Serenity Toric IOL Unfortunately, no peer review studies on the Serenity toric IOL have been published to date; therefore, no direct comparison with our results can be made. However, Daya et al12 analyzed the non-toric model in a prospective multicenter study involving 108 eyes of 54 patients from different countries, with a 3-month follow-up. These authors reported that 79.63% and 98.15% of eyes were within ±0.50D and ±1.00D of the target SE, respectively. The mean SE and cylinder values were –0.06±0.44D and –0.37±0.44D, respectively. Double angle plots revealed a centroid value of 0.20D @ 4 degrees ±0.54D and a mean absolute value of 0.38D±0.43D. Our results for SE showed that 78.26% of eyes were within ±0.50D and 95.65% within ±1.00D. For refractive cylinder, 78.26% of eyes were ≤0.50D and all were ≤1.00D (Figure 1A and B). The mean SE and cylinder were −0.28±0.38D and −0.40±0.26D, respectively. The refractive astigmatism centroid was 0.14±0.46D at 156 degrees, and the mean absolute astigmatism was 0.40±0.25D (Figure 2). Regarding distance visual acuity, Daya et al12 reported that 68.41% and 98.15% of eyes achieved UDVA and CDVA ≥20/20, respectively, while 88.89% and 99.07% achieved ≥20/25, respectively. The mean UDVA and CDVA values were 0.02±0.11 and –0.04±0.05 logMAR, respectively. In our study, the corresponding percentages were 47.62% and 100% for UDVA and CDVA ≥20/20, and 80.98% and 100% for UDVA and CDVA ≥20/25, respectively (Figure 3B), with similar mean values (0.07±0.11 and –0.02±0.04 logMAR, respectively, Table 2). Daya et al12 concluded that eyes implanted with this IOL model achieved good distance visual acuity and accurate refractive outcomes. Our findings with the toric version of the IOL are broadly consistent with these results. The mean rotation in our cohort was 1.70±1.72 degrees, with 91.30% of eyes showing a rotation ≤5 degrees and 100% of eyes ≤10 degrees. FineVision Toric IOL Two clinical studies have analyzed the performance of the FineVision HP toric IOL. Daya and Espinosa15 retrospectively analyzed 62 eyes at 6 weeks post-surgery, reporting that 88.71% of eyes were within ±0.50D and 98.39% were within ±1.00D of the SE, with a mean value of 0.09±0.39D. The mean IOL rotation reported was 5.8 degrees. Akahoshi,16 in a similar retrospective study of Japanese eyes (n=66), found that 98.48% of eyes were within ±0.50D of SE and all were within ±1.00D, with a mean value of 0.00±0.21D. Regarding refractive astigmatism, 95.45% of eyes had ≤0.50D and 100% of eyes had ≤1.00D, with a mean value of –0.08±0.23D. Our results also showed favourable outcomes, with 86.96% of eyes within ±0.50D and 100% within ±1.00D of SE, and a mean value about a quarter of diopter (0.22±0.30D). In terms of refractive astigmatism, 100% of eyes were ≤0.50D, with a mean value of −0.14±0.20D. The mean rotation in our cohort was lower than that reported by Daya and Espinosa,15 at 1.78±1.31 degrees, with 100% of eyes showing a rotation ≤5 degrees. Focusing now on visual acuity outcomes, Daya and Espinosa15 reported that 82.26% and 98.39% of eyes achieved UDVA of ≥20/20 and ≥20/25, respectively, while for CDVA these values were 95.16% and 100%, respectively. The mean UDVA and CDVA were 0.01±0.06 and –0.01±0.04logMAR, respectively. Similarly, Akahoshi16 reported good percentages of cumulative visual acuity at distance, with 87.88% and 90.91% of eyes achieving UDVA and CDVA ≥20/20, respectively, and 98.48% and 100% achieving ≥20/25, respectively. Our results also support these favourable distance vision outcomes: 91.30% and 100% of eyes achieved UDVA ≥20/20 and ≥20/25, respectively; while 95.65% and 100% achieved these thresholds for CDVA (see Figure 3C). Mean UDVA and CDVA were better than 20/20 (–0.03±0.06 and –0.05±0.07 logMAR, respectively, Table 2). Both Daya and Espinosa15 and Akahoshi16 concluded that this IOL provides accurate refractive outcomes with excellent visual acuity. Our findings are consistent with these authors. Comparative Analysis Our refractive outcomes revealed statistically significant differences among the mean values of three IOL groups (p<0.05, Table 2). However, the difference in SE between groups was about ±0.25D, and even smaller for refractive astigmatism, suggesting that the clinical impact is likely negligible. A similar pattern was observed for UDVA and CDVA. In fact, for CDVA, post hoc analysis did not reveal statistically significant differences between any pair of groups (all p>0.05). These findings indicate that, although a modest overall group effect was detected, the intergroup difference were small and not consistently distinguishable in pairwise comparisons. Therefore, all three IOL types showed comparable distance visual acuity outcomes. Rotational outcomes showed no statistically significant differences among groups, either for mean rotation values (p=0.16) or for the proportion of eyes with rotation ≤5 degrees (p=0.108), indicating comparable rotational stability across all groups. This is consistent with previous studies evaluating the POD platform. Li et al12 reported, after analysing by haptic design, that loop haptics are more stable than plate-haptics. Furthermore, double-loop (quad-haptics) and plate loop (closed-loop) designs demonstrate even greater rotational stability than traditional loop haptics. This improved stability may be attributed to the increased number of contact points between the haptics and the capsular bag. The FineVision POD FT toric IOL has demonstrated excellent rotational stability despite its hydrophilic material (pooled mean absolute rotation: 1.53 degrees).2 It should be noted that the FineVision IOL evaluated in our study corresponds to the HP model, which is hydrophobic. A recent review including 19 clinical studies (1428 eyes implanted with the POD platform) concluded that this platform provides good rotational stability across different IOL models, regardless of whether they are monofocal or trifocal, and irrespective of hydrophilic or hydrophobic material.4 The mean rotation across these studies was 2.61 degrees. Therefore, our findings further support the rotational stability of the POD platform, independently of optical design, and confirm its favourable clinical performance. Several limitations in our study should be acknowledged. First, the follow-up period was limited to 3 months. However, it is well established that the most significant IOL rotation occurs within the first month after surgery,18 suggesting that rotational stability can be reasonably assessed within this timeframe. Nevertheless, longer follow-up periods in future clinical studies would be desirable to confirm the absence of late postoperative IOL rotation. Second, the sample size was relatively small and the preoperative statistical significance of some parameters. Larger cohorts are needed to further validate these preliminary findings and strengthen the evidence supporting our conclusions. Conclusions In conclusion, our study suggests that the double C-loop haptic provides excellent refractive, distance visual acuity, and rotational stability for eyes implanted with toric IOLs based on different optic designs. Correct spherical power with appropriate toric IOL provides excellent accuracy of the procedure when the POD platform is used. Surgeons can consider this haptic design for stability independently of the optical design of the IOL model selected during cataract surgery.